Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide vs Mesalazine in Lymphocytic Colitis
NCT01209208Phase 3Completed
- Sponsor
- Dr. Falk Pharma GmbH
- Start
- May 2010
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide, Salcrozine in Lymphocytic Colitis (LC), sponsored by Dr. Falk Pharma GmbH. Started May 2010; status: completed.
02
Drugs
budesonideSalcrozine
03
Conditions
Lymphocytic Colitis (LC)
Beyond the preview
Go deeper on NCT01209208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01209208.